Eligibility NCT00130858 # Soft Tissue Sarcoma
Phase II Study to evaluate the response on two blocks of topotecan and carboplatin

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
UMLS CUI
Item Group
Einschlusskriterien
Gender
Item
boolean
C0079399
263495000
MTHU002975
Age
Item
boolean
C0001779
424144002
MTHU010047
Soft tissue sarcoma chemosensible, stage IV
Item
boolean
C0796624
measurable tumor lesions
Item
boolean
C1302351
399375005
Item Group
Ausschlusskriterien
Lack of cooperation by the patient
Item
boolean
C1321605
405078008
no willingness of follow-up examinations
Item
boolean
C0040809
10056407
105480006
participation on another clinical trial at the same time
Item
boolean
C2347180
C1516879
death due to the sickness within four weeks
Item
boolean
C0023671
MTHU021387
Item Group
Medizinische Konzepte
Age
Item
string
C0001779
424144002
MTHU010047
Gender
Item
string
C0079399
263495000
MTHU002975
Soft tissue sarcoma stage IV
Item
string
C0796624
Tumor size finding
Item
string
C1302351
399375005
Compliance behavior
Item
string
C1321605
405078008
Refusal of Treatment
Item
string
C0040809
10056407
105480006
Subject Enrolled in Study
Item
string
C2347180
Enrollment
Item
string
C1516879
Life Expectancy
Item
string
C0023671
MTHU021387